Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
5
×
life sciences
national blog main
biotech
clinical trials
san francisco
san francisco blog main
san francisco top stories
23andme
archive
biotech ipos
boston
boston blog main
boston top stories
cannabidiol
deals
dravet syndrome
drugs
dyne therapeutics
epidiolex
fen-phen
fenfluramine
food and drug administration
google
gw pharmaceuticals
halle tecco
lennox-gastaut syndrome
medical
medical device
metacrine
myotonic dystrophy type 1
nonalcoholic steatohepatitis
pulmonary arterial hypertension
raleigh-durham blog main
rare disease drugs
rare diseases
rockhealth
salk institute
san diego blog main
san diego top stories
What
rare
5
×
drug
disease
fda
genetic
approval
data
medicine
therapeutics
therapy
administration
ago
andme
app
approved
approves
asked
automatically
battle
big
billion
brings
building
called
cancer
cannabis
cellphones
children
cloud
company
connect
deal
derivative
designed
detects
developer
developing
digital
disorders
doctor’s
Language
unset
Current search:
rare
×
fda
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@slashgear.com
4 years ago
FDA approves $2.1m gene therapy for infants with rare genetic disease
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed
@techcrunch.com
9 years ago
We Asked Rock Health Founder Halle Tecco About The Future Of Digital Medicine